Wheldon T E, Brunton G F
Br J Cancer. 1982 Jan;45(1):1-9. doi: 10.1038/bjc.1982.1.
In tumour regrowth-delay experiments, the analysis of results in the higher dose ranges may be complicated by a dose-dependent proportion of non-recurrent (cured) tumours, whose inclusion in the analysis is not straightforward. A study of the relation of growth delay to cure has been carried out using a model of tumour response which assumes Poisson (single-cell) cure statistics and exponential regrowth kinetics of recurrent tumours, and which makes use of Monte Carlo simulation techniques to represent the effects of inter-tumour heterogeneity. This approach yields correction factors compensating for tumour cures in growth-delay experiments. For homogeneous tumour systems (all tumours and treatments identical) these corrections are small and not significantly different from corrections obtained using the "long delay" procedure suggested previously (Denekamp, 1980; Fowler et al., 1980). For heterogeneous systems, however, correction factors increase with the heterogeneity of the system, and may become quite large. It is concluded that the quantitative assessment of heterogeneity is required, and a possible approach to this is suggested. Should evaluation of heterogeneity prove feasible, it will allow more efficient use of tumour-response data, and may permit realistic estimates of clonogenic cell survival in situ.
在肿瘤再生长延迟实验中,在较高剂量范围内对结果进行分析可能会因非复发性(治愈)肿瘤的剂量依赖性比例而变得复杂,将其纳入分析并非易事。利用肿瘤反应模型开展了一项关于生长延迟与治愈关系的研究,该模型假定泊松(单细胞)治愈统计学以及复发性肿瘤的指数再生长动力学,并利用蒙特卡罗模拟技术来体现肿瘤间异质性的影响。这种方法产生了校正因子,用于补偿生长延迟实验中的肿瘤治愈情况。对于同质肿瘤系统(所有肿瘤和治疗均相同),这些校正值很小,且与之前建议的“长延迟”程序(Denekamp,1980年;Fowler等人,1980年)所获得的校正值无显著差异。然而,对于异质系统,校正因子会随着系统异质性的增加而增大,并且可能会变得相当大。得出的结论是需要对异质性进行定量评估,并提出了一种可能的方法。如果证明对异质性的评估是可行的,那么将能够更有效地利用肿瘤反应数据,并且可能对原位克隆形成细胞的存活情况进行实际估计。